Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer

NCT01394315 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2013-05-03

No results posted yet for this study

Summary

The aim of the study is to determine if DOT can detect response early in breast cancer patients undergoing neoadjuvant chemotherapy.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

Principal Investigators

  • Yoon Sim Yap, MBBS, FRACP · National Cancer Centre, Singapore

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01394315 on ClinicalTrials.gov